Atara Biotherapeutics (ATRA) Earnings Date, Estimates & Call Transcripts $11.57 -0.20 (-1.70%) (As of 03:03 PM ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Atara Biotherapeutics Latest Earnings SummaryLatest Earnings DateNov. 12ConfirmedConsensus EPS (Nov. 12) -$3.77 Atara Biotherapeutics announced Q3 2024 earnings on November 12, 2024, reporting an EPS of $0.00, which topped analysts' consensus estimates of -$3.77 by $3.77. With a trailing EPS of -$39.35, Atara Biotherapeutics' earnings are expected to decrease next year, from ($12.09) to ($16.61) per share. ATRA Upcoming EarningsAtara Biotherapeutics' next earnings date is scheduled for Tuesday, November 12, 2024. Get Atara Biotherapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Atara Biotherapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataATRA Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.ATRA Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Colonial Metals“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as we wait for Trump's agenda to kick in…>> YES! Send Me My FREE Gold Guide! Atara Biotherapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20241-$0.62-$0.62-$0.62Q2 20241$0.06$0.06$0.06Q3 20241-$4.67-$4.67-$4.67Q4 20241-$8.63-$8.63-$8.63FY 20244-$13.86-$13.86-$13.86Q1 20251$3.05$3.05$3.05Q2 20251-$8.08-$8.08-$8.08Q3 20251-$7.84-$7.84-$7.84Q4 20251-$7.62-$7.62-$7.62FY 20254($20.49)($20.49)($20.49) Atara Biotherapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks 11/12/2024(Confirmed)--$3.77----- 8/12/2024Q2 2024-$1.56-$3.10 -$1.54-$3.10$48.30M$28.64M 5/9/2024Q1 2024-$9.25-$5.75+$3.50-$0.23$27.00M$27.36M 3/28/2024Q4 2023-$15.25-$14.00+$1.25-$0.56$2.45M$4.25M 11/1/2023Q3 2023-$15.75-$16.50 -$0.75-$0.66$2.20M$2.14M 8/8/2023Q2 2023-$16.25-$17.00 -$0.75-$0.68$3.36M$0.96M 5/8/2023Q1 2023-$10.00-$18.00 -$8.00-$0.72$37.67M$1.23M Get the Latest News and Ratings for ATRA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Atara Biotherapeutics and its competitors with MarketBeat's FREE daily newsletter. 2/8/2023Q4 2022-$15.25-$18.00 -$2.75-$0.72$60.00M$0.22M Atara Biotherapeutics Earnings - Frequently Asked Questions When is Atara Biotherapeutics's earnings date? Atara Biotherapeutics has confirmed that its next quarterly earnings data will be published on Tuesday, November 12th, 2024. Learn more on ATRA's earnings history. Did Atara Biotherapeutics beat their earnings estimates last quarter? In the previous quarter, Atara Biotherapeutics (NASDAQ:ATRA) reported $0.00 earnings per share (EPS) to beat the analysts' consensus estimate of ($3.77) by $3.77. Learn more on analysts' earnings estimate vs. ATRA's actual earnings. How much revenue does Atara Biotherapeutics generate each year? Atara Biotherapeutics (NASDAQ:ATRA) has a recorded annual revenue of $8.57 million. How much profit does Atara Biotherapeutics generate each year? Atara Biotherapeutics (NASDAQ:ATRA) has a recorded net income of -$276.13 million. ATRA has generated -$39.35 earnings per share over the last four quarters. What is Atara Biotherapeutics's EPS forecast for next year? Atara Biotherapeutics's earnings are expected to decrease from ($12.09) per share to ($16.61) per share in the next year. ` More Earnings Resources from MarketBeat Related Companies ALVR Earnings SCLX Earnings OGI Earnings GOSS Earnings ELDN Earnings MDWD Earnings DMAC Earnings BDTX Earnings ATAI Earnings LFVN Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead?Apple Earnings - When Really Good Just Isn’t Good Enough Roblox Stock Set for More Gains After Strong Earnings ReportAmazon: Why Analysts Think It's a Solid Buy Ahead of EarningsLam Research Proves Analysts Wrong with a Strong Earnings ReportPulteGroup Earnings Signal Potential Entry Points for InvestorsTaiwan Semiconductor Soars on Earnings With More Room to Run “This Changes Everything” - Trump Hands Millions Massive IRS Gift (Ad)Now it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as we wait for Trump's agenda to kick in…>> YES! Send Me My FREE Gold Guide! This page (NASDAQ:ATRA) was last updated on 11/12/2024 by MarketBeat.com Staff From Our PartnersAmazon's $150B Data Center Bet—What It Means for Uranium InvestorsAmazon is placing a massive bet on nuclear energy to power its $150 billion data center expansion. With dem...The Bull Report | SponsoredOptions Trading on Bitcoin?SEC Approves Crypto Options Trading Select altcoins poised for RAPID growth by early 2025… Crypto 101 Media | SponsoredCentral Bank Abandons USDStartling new evidence shows the U.S. Central Bank is abandoning the currency we’ve relied on for centuries – ...True Gold Republic | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersTrump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax...Colonial Metals | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredCritical warning from the mountains of CarolinaNvidia CEO Jensen Huang says Big Tech will spend over $1 trillion on data centers. And that still might not...Weiss Ratings | SponsoredCrypto’s FINAL Wealth MomentBitcoin’s final bull market is here. If you missed out on the gains in 2017, or 2021… 2025 stands to be jus...Paradigm Press | SponsoredWhy Trump’s Win Can’t Stop the Coming Crisis - Protect Yourself NowNo matter who sits in the White House over the next four years, a series of events has been triggered that cou...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Atara Biotherapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Atara Biotherapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ATRA Stock Alerts